Financial Performance - Ecolab's reported diluted EPS was $1.84, with adjusted diluted EPS at $1.89, a 13% increase[7, 12] - The company anticipates full-year 2025 adjusted diluted earnings per share to be in the range of $7.42 to $7.62, representing a 12% to 15% increase compared to 2024[8, 15] - Ecolab projects third-quarter 2025 adjusted diluted earnings per share to be between $2.02 and $2.12, a 10% to 16% rise from the previous year[8, 15] - Reported sales increased by 1%, which includes an unfavorable impact of 2% from the sale of the global surgical solutions business[8] - Organic sales grew by 3%, driven by Institutional & Specialty and Water segments[8] - Reported operating income (OI) increased by 8%, with organic OI rising by 14%[8] - Organic operating income margin expanded by 170 bps to 18.3%, attributed to value pricing and improved productivity[8] Segment Performance - Global Water segment sales increased by 2%[16] - Global Institutional & Specialty segment sales increased by 4%[16] - Global Pest Elimination segment sales increased by 6%[16] - Global Life Sciences segment sales increased by 4%[16] Strategic Outlook - Ecolab expects to achieve a 20% operating income margin by 2027[7] - The company is focused on capitalizing on long-term growth opportunities, maximizing service effectiveness, and leveraging investments in digital technology[37] - Ecolab is well-prepared to manage the dynamic international trade environment through its world-class supply chain, 'local for local' production model, and recently implemented trade surcharge[15]

Financial Performance - Reported diluted EPS was $1.41, while adjusted diluted EPS reached $1.50, a 12% increase[6,12] - Organic sales grew by 3%, driven by strong performance in Institutional & Specialty, Pest Elimination, and Life Sciences segments[7,11] - The company anticipates full-year 2025 adjusted diluted earnings per share to be in the range of $7.42 to $7.62, representing a 12% to 15% increase compared to 2024[7,16] - For the second quarter of 2025, adjusted diluted earnings per share are expected to be between $1.84 and $1.94, a 10% to 15% increase[7,16] Segment Performance - Global Water segment sales increased by 3% in Light & Heavy and 2% in Food & Beverage[19,25] - Global Institutional & Specialty segment sales grew by 4%, with 5% growth in the legacy Institutional business[13,31] - Global Pest Elimination and Life Sciences segments both experienced a 5% increase in sales[13,38,44] Margin Expansion - Reported operating income (OI) increased by 7%, while organic OI rose by 17%[7] - Organic OI margin expanded by 190 bps to 16%, driven by value pricing and improved productivity[7] - Adjusted gross margin improved to 44.4%, up from 43.3%[51,56] Strategic Outlook - The company expects to deliver continued 12-15% EPS growth in 2025 and beyond[6] - Secular growth trends in water, hygiene, and infection prevention are expected to fuel long-term demand[16] - Ecolab is making proactive adjustments to overcome the unpredictable operating environment through new business wins, value and surcharge pricing, and improved productivity[7,16]